Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Shugo, Tamada"'
Autor:
Yoshihisa Umekita, Akihide Tanimoto, Yasuaki Sagara, Masakazu Souda, Orie Iwaya, Daisuke Yotsumoto, Yasuyo Ohi, Shugo Tamada
Publikováno v:
Histopathology. 73(6)
AIMS Maspin is known to be a tumour suppressor protein, but its prognostic significance in breast cancer patients is controversial. There is no report focusing on maspin expression in metastatic carcinoma of sentinel lymph nodes (SLNs); we thus inves
Autor:
Ayami Matsukata, Shugo Tamada, Yoshiaki Sagara, Shinichi Baba, Yoshiaki Rai, Yoshito Matsuyama, Yasuaki Sagara, Yoshiatsu Sagara, Yasuyo Ohi, Mitsutake Ando, Daisuke Yotsumoto
Publikováno v:
Breast Cancer. 20:181-186
The one-step nucleic acid amplification (OSNA) method can assess the expression level of cytokeratin 19 mRNA in sentinel lymph nodes in breast cancer. We compared the time required for diagnosis and concordance of results between the OSNA method and
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72:10-14
左乳房に腫瘤を形成,画像診断で乳癌を否定できず組織生検を施行,巨細胞性動脈炎Giant cell arteritis(GCA)の診断に至った症例を経験した.症例は74歳,女性.左乳房に圧痛を伴う腫瘤を
Autor:
Masamichi Goto, Masato Nagino, Hiroaki Shibahara, Shugo Tamada, Yuji Nimura, Tetsuro Nagasaka, Michael A. Hollingsworth, Surinder K. Batra, Koji Oda, Suguru Yonezawa, Kohzoh Imai
Publikováno v:
The American Journal of Surgical Pathology. 28:327-338
Tumors with clinically recognizable mucin production arising from bile duct, "mucin-producing bile duct tumors (MPBTs)," have not been studied yet for their pathologic features and classification in details. The clinical findings of MPBT have a lot o
Autor:
Shugo, Tamada, Yasuaki, Sagara, Shinichi, Baba, Yoshiaki, Sagara, Daisuke, Yotsumoto, Ayami, Matsukata, Mitsutake, Andou, Yoshiatsu, Sagara, Yoshiaki, Rai
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(4)
We experienced a case of endocrine therapy-resistant recurrent breast cancer with liver and bone metastases, treated with S-1 as first-line chemotherapy and maintaining a good quality of life. The patient was a 31-year-old premenopausal woman. She wa
Autor:
Takako Yoshioka, Shugo Tamada, Yasuaki Sagara, Yoshiaki Rai, Akihide Tanimoto, Yoshihisa Umekita, Yasuyo Ohi, Taeko Kukita, Yoshiaki Sagara, Shinichi Baba, Kazuhito Hatanaka, Yoshiatsu Sagara
Publikováno v:
Diagnostic Pathology
Diagnostic Pathology, Vol 6, Iss 1, p 29 (2011)
Diagnostic Pathology, Vol 6, Iss 1, p 29 (2011)
Background Mucocele-like lesions (MLL) of the breast were originally described as benign lesions composed of multiple cysts lined by uniform flat to cuboidal epithelium with extravasated mucin, but subsequent reports described the coexistence of colu
Autor:
Akihide Tanimoto, Masakazu Souda, Shugo Tamada, Yoshihisa Umekita, Yoshiaki Sagara, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara
Publikováno v:
Diagnostic Pathology
Diagnostic Pathology, Vol 6, Iss 1, p 36 (2011)
Diagnostic Pathology, Vol 6, Iss 1, p 36 (2011)
Background Maspin is a unique member of the serine protease inhibitor superfamily and its expression is found in myoepithelial cells of normal mammary glands; therefore, it has been considered to be a myoepithelial marker. We previously reported that
Autor:
Yoshiaki, Sagara, Yoshiaki, Rai, Yoshiatsu, Sagara, Yoshito, Matsuyama, Shinichi, Baba, Shugo, Tamada, Yasuaki, Sagara, Mitsutake, Ando
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(2)
A paclitaxel injection NK (NK) is a generic product containing the same amount of ingredient as a Taxol Injection. We examined the pharmacokinetics and safety of NK compared to the original product in breast cancer patients. As a result, the transiti
Publikováno v:
Liver Cancer ISBN: 9781402098031
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bb49bf28a3481974570025cd2ce5010
https://doi.org/10.1007/978-1-4020-9804-8_34
https://doi.org/10.1007/978-1-4020-9804-8_34
Autor:
Yasuaki Sagara, Yoshito Matsuyama, Yoshiaki Sagara, Shinichi Baba, Shugo Tamada, Tsutomu Douchi, Yoshiatsu Sagara, Fumiko Dokiya, Mitsutake Ando, Yoshiaki Rai, Yasuyo Ohi, Shoichiro Kosha
Publikováno v:
Breast cancer (Tokyo, Japan). 17(3)
Although anastrozole (ANA), an aromatase inhibitor (AI), has been widely used for breast cancer patients; adverse events during ANA therapy in Japanese patients have not been reported. The study included 656 postmenopausal breast cancer patients rece